Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,877Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Zytiga

02 2Zytiga

PharmaCompass

01

Brand Name : Zytiga

Abiraterone Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Zytiga

arrow
Medlab Asia & Asia Health
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 2,470

2019 Revenue in Millions : 2,795

Growth (%) : -12

blank

02

Brand Name : Zytiga

Abiraterone Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Zytiga

arrow
Medlab Asia & Asia Health
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 2,297

2020 Revenue in Millions : 2,470

Growth (%) : -7

blank

03

Brand Name : Zytiga

Abiraterone Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Zytiga

arrow
Medlab Asia & Asia Health
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 1,770

2021 Revenue in Millions : 2,297

Growth (%) : -23

blank

04

Brand Name : Zytiga

Abiraterone Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Zytiga

arrow
Medlab Asia & Asia Health
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 887

2022 Revenue in Millions : 1,770

Growth (%) : -50

blank

05

Brand Name : Zytiga

Abiraterone Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Zytiga

arrow
Medlab Asia & Asia Health
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2014 Revenue in Millions : 31.70%

2013 Revenue in Millions :

Growth (%) :

blank

06

Brand Name : Zytiga

Abiraterone Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Zytiga

arrow
Medlab Asia & Asia Health
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 2,237

2014 Revenue in Millions : 2,231

Growth (%) : 0%

blank

07

Brand Name : Zytiga

Abiraterone Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Zytiga

arrow
Medlab Asia & Asia Health
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 2,260

2015 Revenue in Millions : 2,231

Growth (%) : 1

blank

08

Brand Name : Zytiga

Abiraterone Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Zytiga

arrow
Medlab Asia & Asia Health
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 2,505

2016 Revenue in Millions : 2,260

Growth (%) : 11

blank

09

Brand Name : Zytiga

Abiraterone Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Zytiga

arrow
Medlab Asia & Asia Health
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 3,498

2017 Revenue in Millions : 2,505

Growth (%) : 40%

blank

10

Brand Name : Zytiga

Abiraterone Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Zytiga

arrow
Medlab Asia & Asia Health
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 2,795

2018 Revenue in Millions : 3,498

Growth (%) : -20

blank